These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Guidelines for treating patients taking bisphosphonates prior to dental extractions. Rogers S, Rahman N, Ryan D, Flint S, Healy C, Stassen LF. J Ir Dent Assoc; 2010; 56(1):40. PubMed ID: 20337145 [No Abstract] [Full Text] [Related]
3. Bisphosphonates and bisphosphonate induced osteonecrosis. Sawatari Y, Marx RE. Oral Maxillofac Surg Clin North Am; 2007 Nov; 19(4):487-98, v-vi. PubMed ID: 18088900 [Abstract] [Full Text] [Related]
4. Management of bisphosphonate-induced osteonecrosis of the jaw. Schilling J. Northwest Dent; 2008 Nov; 87(3):34-5, 37-8, 40. PubMed ID: 18663869 [Abstract] [Full Text] [Related]
5. [Bisphosphonates (BP) and osteonecrosis of the jaws; should administration of BP be discontinued at the early phase?]. Urade M. Clin Calcium; 2010 Nov; 20(11):1740-3. PubMed ID: 21066911 [No Abstract] [Full Text] [Related]
6. CTX and its role in managing patients exposed to oral bisphosphonates. Dodson TB. J Oral Maxillofac Surg; 2010 Feb; 68(2):487-8; author reply 488-9. PubMed ID: 20116729 [No Abstract] [Full Text] [Related]
7. [Bisphosphonates (BP) and osteonecrosis of the jaws; continuous treatment with Bisphosphonates should be considered]. Mawatari T. Clin Calcium; 2010 Nov; 20(11):1743-7. PubMed ID: 21066910 [No Abstract] [Full Text] [Related]
8. Osteonecrosis in the jaws of patients who are using oral biphosphonates to treat osteoporosis. Dello Russo NM, Jeffcoat MK, Marx RE, Fugazzotto P. Int J Oral Maxillofac Implants; 2007 Nov; 22(1):146-53. PubMed ID: 17340909 [No Abstract] [Full Text] [Related]
14. Management of patients on bisphosphonates and prevention of bisphosphonate-related osteonecrosis of the jaw. Chu V, American Association of Oral and Maxillofacial Surgeons, American Dental Association. Hawaii Dent J; 2008 Jun; 39(5):9-12; quiz 17. PubMed ID: 19189512 [Abstract] [Full Text] [Related]
15. Serologic bone markers for predicting development of osteonecrosis of the jaw in patients receiving bisphosphonates. Lazarovici TS, Mesilaty-Gross S, Vered I, Pariente C, Kanety H, Givol N, Yahalom R, Taicher S, Yarom N. J Oral Maxillofac Surg; 2010 Sep; 68(9):2241-7. PubMed ID: 20728033 [Abstract] [Full Text] [Related]
17. Tooth extraction in patients taking intravenous bisphosphonates: a preventive protocol and case series. Lodi G, Sardella A, Salis A, Demarosi F, Tarozzi M, Carrassi A. J Oral Maxillofac Surg; 2010 Jan; 68(1):107-10. PubMed ID: 20006163 [Abstract] [Full Text] [Related]
19. Tooth extraction: Is it inciting event or sequela of osteonecrosis of the jaws associated with intravenous bisphosphonates? Altundag K, Bulut N, Tezcan E, Ozen M, Purnak T. J Oral Maxillofac Surg; 2007 Jan; 65(1):154. PubMed ID: 17174785 [No Abstract] [Full Text] [Related]
20. Bisphosphonate-induced osteonecrosis of the jaw: a medical enigma? Siddiqi A, Payne AG, Zafar S. Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2009 Sep; 108(3):e1-8. PubMed ID: 19570696 [Abstract] [Full Text] [Related] Page: [Next] [New Search]